Lipoprotein (a) in patients with spontaneous venous thromboembolism

Rainer Vormittag1, Thomas Vukovich, Milena Stain

  • 1Department of Internal Medicine I, Division of Hematology and Blood Coagulation, University Hospital of Vienna, Austria.

Thrombosis Research
|April 29, 2006
PubMed

Insights

Elevated lipoprotein (a) (Lp (a)) is not associated with an increased risk of venous thromboembolism (VTE). This study found no significant difference in Lp (a) levels between patients with deep vein thrombosis or pulmonary embolism and healthy controls.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis Research
  • Lipidology

Background:

  • Elevated lipoprotein (a) (Lp (a)) is a known risk factor for coronary heart disease and stroke.
  • Previous studies on the association between Lp (a) and venous thromboembolism (VTE) have yielded contradictory results.
  • Investigating Lp (a) as a potential independent risk factor for VTE is crucial for understanding thrombosis risk profiles.

Purpose of the Study:

  • To determine if elevated Lp (a) levels are an independent risk factor for spontaneous symptomatic VTE.
  • To compare risk profiles between patients with thrombosis and healthy controls.
  • To analyze differences in Lp (a) levels in patients with deep vein thrombosis (DVT) and pulmonary embolism (PE).

Main Methods:

  • Investigated Lp (a) levels in 128 patients with DVT, 105 patients with PE, and 122 healthy controls.
  • Measured Lp (a) using an immunoturbidimetric assay (Tina-quant(R), Roche).
  • Analyzed Lp (a) levels as both continuous and categorical variables (above 300 mg/L).

Main Results:

  • Median Lp (a) levels (mg/L) were similar across groups: 170 in DVT patients, 140 in PE patients, and 126 in controls.
  • Odds ratios for VTE per 100 mg/L increase in Lp (a) were not statistically significant.
  • Prevalence of Lp (a) > 300 mg/L did not differ significantly among DVT, PE, and control groups.

Conclusions:

  • No association was found between Lp (a) levels and the risk of VTE.
  • This finding applies regardless of whether DVT occurred with or without PE.
  • Lp (a) does not appear to be an independent risk factor for spontaneous symptomatic VTE.
Abstract

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...